Support for men with prostate cancer

Talking to other men and caregivers facing the same challenges can be immensely helpful. Below is a list of organizations that provide support groups, as well as resources, for men living with prostate cancer.

Get the support you need

Advocacy

Prostate cancer advocacy groups help you and your loved ones navigate the cancer landscape. They can connect you with medical professionals, support groups and financial assistance. Advocacy groups also raise funds for advancing treatment options.

Patient Advocates for Advanced Cancer Treatments, Inc. (PAACT)

www.paactusa.org

1-616-453-1477

Prostate Cancer Foundation

www.pcf.org

1-800-757-CURE (2873)

Prostate Cancer Research Institute

www.pcri.org

1-800-641-PCRI (7274)

US Too

www.ustoo.org

1-800-808-7866

ZERO ­— The End of Prostate Cancer

www.zerocancer.org

1-888-245-9455

Education

Becoming your own advocate means learning as much as you can about prostate cancer. The following organizations will help you learn about your condition, treatment options and how you can support your medical care through healthy lifestyle choices.

Men’s Health Network

www.menshealthnetwork.org

1-202-543-MHN-1 (6461) ext.101

Urology Care Foundation

www.urologyhealth.org

1-800-828-7866

American Cancer Society®

www.cancer.org

(see “Learn About Cancer”)

1-800-227-2345

Blue Cure®

www.bluecure.org

Prostate Health Education Network, Inc.

www.prostatehealthed.org

Financial assistance

You may be nervous about the financial aspects of being diagnosed with cancer, but there are many organizations dedicated to helping you with those costs. You should also check with your doctor’s office to see if other assistance is available.

Financial assistance

You may be nervous about the financial aspects of being diagnosed with cancer, but there are many organizations dedicated to helping you with those costs. Speak with the organizations below to see what type of assistance they may be able to offer. You should also check with your doctor’s office to see if other assistance is available.

BenefitsCheckUp®

www.benefitscheckup.org

CFAC: Cancer Financial Assistance Coalition

www.cancerfac.org

CancerCare®​ Co-Payment Assistance Foundation

www.cancercarecopay.org

1-866-55-COPAY (2-6729) or

1-212-601-9750

Health Well Foundation®

www.healthwellfoundation.org

1-800-675-8416

Medicine Assistance Tool

www.medicineassistancetool.org

Patient Advocate Foundation

www.copays.org

1-866-512-3861

Important Safety Information

ELIGARD®​ is used for the palliative treatment of advanced prostate cancer. ELIGARD is a prescription medication that must be administered by a health care professional.

  • ELIGARD should not be used by anyone who is allergic to any of the ingredients in ELIGARD or to any similar drugs.
  • ELIGARD causes an increase in testosterone during the first few weeks of therapy and some men may experience new or worsening symptoms of prostate cancer e.g., bone pain, urinary symptoms, or nerve problems such as numbness, during this period. If your cancer has spread to the urinary tract or spine, urinary blockage or pressure on the spine that can lead to paralysis may occur. Your doctor will discuss with you the benefits and risks of taking ELIGARD.
  • Increased risk of heart attack, sudden death due to heart problems and stroke have also been reported in men taking ELIGARD. ELIGARD may also affect electrical activity in the heart that can cause an irregular heartbeat. Your doctor will monitor you for heart conditions.
  • Elevated blood sugar and an increased risk of developing diabetes have been reported in men receiving ELIGARD. Your doctor will monitor blood sugar levels.
  • Convulsions have been observed in patients taking leuprolide acetate, including patients who have a history of seizures, epilepsy, or brain disorders (related to blood vessels, nerves, or tumors), and in those taking medications associated with convulsions. Convulsions have also been reported in patients without any of these conditions.
  • ELIGARD may cause fetal harm when administered to a pregnant woman. Expected hormonal changes that occur with ELIGARD treatment increase the risk for pregnancy loss.
  • ELIGARD may impair fertility in males of reproductive potential.

The most common injection site reactions are transient burning and stinging, pain, bruising, and redness. The most common side effects include hot flashes/sweats, fatigue, weakness, muscle pain, dizziness, clamminess, testicular shrinkage, decreased erections and enlargement of breasts. Other side effects, including thinning of bones that may lead to fracture, and rare but serious problems with the pituitary gland in the brain, have been reported with ELIGARD.

These are not all the possible side effects of ELIGARD. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see Full Prescribing Information​ for additional Important Safety Information.

References
  1. Key Statistics for Prostate Cancer. American Cancer Society Website. https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html. Accessed July 2020.
  2. Risk Factors for Prostate Cancer. Cancer Treatment Centers of America Website. https://www.cancercenter.com/cancer-types/prostate-cancer/risk-factors. Accessed July 2020.
  3. ELIGARD®​ (leuprolide acetate) for injectable suspension, 7.5 mg, 22.5 mg, 30 mg, 45 mg prescribing information. Fort Collins, CO: Tolmar Therapeutics, Inc.; 2019.
  4. https://www.nccn.org/patients/guidelines/prostate/index.html. Accessed January 2020
  5. Sartor O. Eur Urol 2006
  6. Prettyman, Urologic Nursing​ 2019

©2020 Tolmar Pharmaceuticals, Inc. All rights reserved. Tolmar, ELIGARD, Tolmar TotalSolutions and their associated logos are trademarks of the Tolmar group. Third party trademarks, product names, and copyrights belong to their respective owners. TPI.2020.2518.v1 (v1.0)

Important Safety Information

See More

+

See Less

ELIGARD®​ is used for the palliative treatment of advanced prostate cancer. ELIGARD is a prescription medication that must be administered by a health care professional.

  • ELIGARD should not be used by anyone who is allergic to any of the ingredients in ELIGARD or to any similar drugs.

ELIGARD®​ is used for the palliative treatment of advanced prostate cancer. ELIGARD is a prescription medication that must be administered by a health care professional.